Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

OLANZAPINE

SUPPORTING DATA

Marketing information
Key claims
Reduced relapse rate
Longer time to relapse
At least as effective as lithium
OFC in bipolar depression
No treatment-emergent mania
Supporting data
Improvements in HR-Qol
Fewer drop-outs than lithium
No QTc prolongation
Usage
Country information
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. OFC in bipolar depression Author: Tohen, et al. Title: Efficacy of olanzapine and olanzapine/fluoxetine combination in... 2. Rate of treatment-emergent mania with OFC Author: Keck, et al. Title: Analysis of treatment-emergent mania with olanzapine/fluoxetine... 3. Olanzapine for maintenance of bipolar disorder Authors: Tohen, et al. Title: Olanzapine’s efficacy for relapse prevention in... 4. Olanzapine vs lithium for prevention of relapse Author: Tohen, et al. Title: Olanzapine versus lithium in relapse prevention in bipolar...